The role of GPS2 in regulating proliferation, migration and invasion of hepatocellular carcinoma cell line MHCC-97H

doi:10.16352/j.issn.1001-6325.2023.12.1784

Abstract

Abstract: Objective To explore the role of G protein pathway suppressor 2(GPS2)in regulating proliferation, migration and invasion in hepatocellular carcinoma cell line MHCC-97H.Methods The expression of GPS2 in hepatocellular carcinoma (HCC) cells were detected using quantitative PCR or Western blot; GPS2 was either over-expressed or knocked down in HCC cells using over-expression vectors or short hairpin RNAs (shRNAs) for GPS2, respectively. Clone formation assay, scratch assay and Transwell assay were used to detect the effects of GPS2 on proliferation, migration and invasion of HCC cells. Results In HCC cells, over-expression of GPS2 was found to inhibit the proliferation, migration and invasion of HCC cells MHCC-97H, while knockdown of GPS2 up-regulated proliferation, migration and invasion of MHCC-97H(P＜0.05). The over-expression of GPS2 in MHCC-97H cells was found to inhibit the expression of cell proliferation, migration and invasion-related factors such as EGFR, MMP1, MMP3 and MMP9, while knockdown of GPS2 upregulated the expression of these factors(P＜0.05). Conclusions GPS2 is a novel HCC regulatory factor that inhibits proliferation, migration and invasion of HCC cells.

Key words: hepatocellular carcinoma, G protein pathway suppressor 2(GPS2), cell proliferation, migration and invasion

CLC Number:

R394.3

LIU Aixia, ZHANG Hao, SUN Jie, YANG Lihua, ZHAO Xiaotao. The role of GPS2 in regulating proliferation, migration and invasion of hepatocellular carcinoma cell line MHCC-97H[J]. Basic & Clinical Medicine, 2023, 43(12): 1784-1791.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.12.1784

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I12/1784

References 15

[1]	Sung H,Ferlay J,Siegel RL,et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71:209-249.
[2]	Feng R, Su Q, Huang X, et al. Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration[J]. Cancer Commun (Lond),2023,43:75-86.
[3]	黄海良,丁伟伟,李冬雪.CRNDE过表达促进人肝癌细胞系HepG2 增殖和迁移[J].基础医学与临床,2020,40:219-223.
[4]	Spain BH, Bowdish KS, Pacal AR,et al.Two human cDNAs, including a homolog of Arabidopsis FUS6 (COP11), suppress G-protein- and mitogen-activated protein kinase-mediated signal transduction in yeast and mammalian cells[J].Mol Cell Biol,1996,16:698-706.
[5]	Cheng X, Kao HY. G protein pathway suppressor 2 (GPS2) is a transcriptional corepressor important for estrogen receptor alpha-mediated transcriptional regulation[J]. J Biol Chem,2009,284:36395-36404.
[6]	Lee TH, Yi W, Griswold MD,et al.Formation of hMSH4-hMSH5 heterocomplex is a prerequisite for subsequent GPS2 recruitment[J]. DNA Repair (Amst),2006,5:32-42.
[7]	Peng YC, Breiding DE, Sverdrup F,et al.AMF-1/Gps2 binds p300 and enhances its interaction with papillomavi-rus E2 proteins[J]. J Virol, 2000,74:5872-5879.
[8]	Si Y, Zhang H, Peng P,et al.G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptor[J]. Cancer Sci,2021,112: 4867-4882.
[9]	熊艺琏,钱琛,吴慧,等.GPS2降低表皮生长因子受体稳定性抑制胃癌恶性进展[J].湖北医药学院报,2023,42:15-23+2.
[10]	李蓝星,张音洁,金永东.靶向联合免疫治疗在不可切除肝细胞癌的临床研究进展[J].肿瘤预防与治疗,2022,35:861-874.
[11]	贾谷和,邵佳康,赵晓,等.表皮生长因子受体靶向药物在肝细胞癌中作用机制的研究进展[J].解放军医学院学报,2022,43:891-895.
[12]	Chan S,Smith E,Gao Y,et al. Loss of G-protein pathway suppressor 2 promotes tumor growth through activation of AKT signaling[J]. Front Cell Dev Biol,2021,8:608044.doi: 10.3389/fcell.2020.608044.
[13]	Shi S,Chen H,Wang H, et al. Genome-wide CRISPR knockout screening identified G protein pathway suppres-sor2 as a novel tumor suppressor for uveal melanoma metastasis[J]. J Cancer Res Clin Oncol,2023,149:3349-3360.
[14]	Huang X,Xiao F,Wang S,et al. G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma[J]. Tumor Biol,2016,37:13333-13343.
[15]	O′Meara E, Stack D, Phelan S, et al. Identification of an MLL4-GPS2 fusion as an oncogenic driver of undifferentiated spindle cell sarcoma in a child[J]. Genes Chrom Cancer,2014, 53:991-998.